AbbVie (ABBV) has sought an injunction to stop the European Medicines Agency from releasing...

|About: AbbVie Inc. (ABBV)|By:, SA News Editor

AbbVie (ABBV) has sought an injunction to stop the European Medicines Agency from releasing "confidential" and "commercially-sensitive" trial-data about Humira, the company's blockbuster rheumatoid arthritis drug. AbbVie's lawsuit follows two Freedom of Information requests to the agency last year for "raw data" about the medicine's safety and efficacy, including from Belgian drug company UCB.